CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 233 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $317,000 | +7.8% | 6,981 | +25.3% | 0.07% | +1.4% |
| Q1 2018 | $294,000 | -22.8% | 5,573 | -0.6% | 0.07% | -19.1% |
| Q4 2017 | $381,000 | +0.3% | 5,605 | +21.6% | 0.09% | -5.3% |
| Q3 2017 | $380,000 | -26.1% | 4,609 | -16.0% | 0.09% | -29.9% |
| Q2 2017 | $514,000 | +53.0% | 5,485 | +4.0% | 0.13% | +52.3% |
| Q1 2017 | $336,000 | +4.0% | 5,273 | -27.4% | 0.09% | -3.3% |
| Q4 2016 | $323,000 | – | 7,268 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $1,200,000 | 4.04% |
| Palo Alto Investors LP | 4,469,411 | $21,453,000 | 1.12% |
| ARMISTICE CAPITAL, LLC | 2,256,000 | $10,829,000 | 0.37% |
| Vigilare Wealth Management | 32,200 | $155,000 | 0.15% |
| Ikarian Capital, LLC | 650,000 | $3,121,000 | 0.14% |
| Ikarian Capital, LLC | 642,108 | $3,082,000 | 0.14% |
| WELD CAPITAL MANAGEMENT LLC | 40,156 | $193,000 | 0.08% |
| PINNACLE ASSOCIATES LTD | 703,970 | $3,379,000 | 0.07% |
| Versant Venture Management, LLC | 101,855 | $489,000 | 0.05% |
| Kalos Management, Inc. | 23,750 | $114,000 | 0.05% |